GEODE CAPITAL MANAGEMENT, LLC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 40 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$3,102,502
+3.5%
251,585
+3.2%
0.00%
Q2 2023$2,998,764
+87.5%
243,802
+87.3%
0.00%
Q1 2023$1,599,715
+103912.7%
130,164
-3.0%
0.00%
Q4 2022$1,538
-99.6%
134,226
+33.2%
0.00%
Q3 2022$378,000
-36.9%
100,8080.0%0.00%
Q2 2022$599,000
-4.9%
100,808
+1.1%
0.00%
Q1 2022$630,000
+66.7%
99,662
+3.1%
0.00%
Q4 2021$378,000
-19.1%
96,6920.0%0.00%
Q3 2021$467,000
-24.3%
96,6920.0%0.00%
Q2 2021$617,000
+7.9%
96,692
+6.0%
0.00%
Q1 2021$572,000
-0.5%
91,208
+9.3%
0.00%
Q4 2020$575,000
+72.7%
83,4840.0%0.00%
Q3 2020$333,000
+23.3%
83,484
+2.9%
0.00%
Q2 2020$270,000
+55.2%
81,1470.0%0.00%
Q1 2020$174,000
-65.9%
81,147
-50.0%
0.00%
Q4 2019$510,000
+40.5%
162,294
+100.6%
0.00%
Q3 2019$363,000
-25.8%
80,8980.0%0.00%
Q2 2019$489,000
-13.0%
80,8980.0%0.00%
Q1 2019$562,000
-13.0%
80,898
-51.7%
0.00%
Q4 2018$646,000
+45.8%
167,574
+101.4%
0.00%
Q3 2018$443,000
+9.7%
83,213
+1.1%
0.00%
Q2 2018$404,000
-54.3%
82,341
-25.1%
0.00%
Q1 2018$884,000
-20.6%
109,879
+1.2%
0.00%
Q4 2017$1,113,000
-26.0%
108,621
+5.0%
0.00%
-100.0%
Q3 2017$1,504,000103,4610.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Western Standard LLC 1,894,013$23,353,18021.09%
Newtyn Management, LLC 1,873,694$23,102,6475.70%
Sio Capital Management, LLC 288,466$3,556,7861.10%
Madison Avenue Partners, LP 553,085$6,819,5380.97%
WITTENBERG INVESTMENT MANAGEMENT, INC. 209,739$2,5860.95%
Indaba Capital Management, L.P. 136,802$1,686,7690.50%
Sepio Capital, LP 306,680$3,781,3640.33%
Yakira Capital Management, Inc. 54,118$667,2750.18%
Centiva Capital, LP 187,803$2,315,6110.05%
FIFTH LANE CAPITAL, LP 10,929$134,4270.05%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders